Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
Gastroenterology|May 1, 1996
Primary sclerosing cholangitis is associated with nonsmoking: a case-control studyE V Loftus, W J Sandborn, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERER Panaccione, J-F Colombel, W J Sandborn, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionW J Sandborn, J E Hay, M K Porayko, et al.
The American Journal of Gastroenterology|August 22, 2001
A prospective cohort study of practice guidelines in inflammatory bowel diseaseW J Tremaine, W J Sandborn, E V Loftus, et al.
Gastrointestinal Endoscopy|January 30, 1999
Acute major gastrointestinal hemorrhage in inflammatory bowel diseaseD S Pardi, E V Loftus, W J Tremaine, et al.
Journal of Chromatography. B, Biomedical Applications|April 26, 1996
Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatographyE C Van Os, J A McKinney, B J Zins, et al.
Alimentary Pharmacology & Therapeutics|June 5, 2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's diseaseW J Sandborn, D E Elliott, J Weinstock, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.
Gut|January 21, 2006
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004T Jess, E V Loftus, W S Harmsen, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2015
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studiesW J Sandborn, S Danese, G D'Haens, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Gastroenterology|May 1, 1996
Primary sclerosing cholangitis is associated with nonsmoking: a case-control studyE V Loftus, W J Sandborn, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics|October 19, 2013
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERER Panaccione, J-F Colombel, W J Sandborn, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionW J Sandborn, J E Hay, M K Porayko, et al.
The American Journal of Gastroenterology|August 22, 2001
A prospective cohort study of practice guidelines in inflammatory bowel diseaseW J Tremaine, W J Sandborn, E V Loftus, et al.
Gastrointestinal Endoscopy|January 30, 1999
Acute major gastrointestinal hemorrhage in inflammatory bowel diseaseD S Pardi, E V Loftus, W J Tremaine, et al.
Journal of Chromatography. B, Biomedical Applications|April 26, 1996
Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatographyE C Van Os, J A McKinney, B J Zins, et al.
Alimentary Pharmacology & Therapeutics|June 5, 2013
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's diseaseW J Sandborn, D E Elliott, J Weinstock, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2011
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's diseaseM A Kamm, S B Hanauer, R Panaccione, et al.
Gut|January 21, 2006
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004T Jess, E V Loftus, W S Harmsen, et al.
Alimentary Pharmacology & Therapeutics|January 16, 2015
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studiesW J Sandborn, S Danese, G D'Haens, et al.
Pageof 19